Glioblastoma

All the information about the symptoms, diagnosis, treatments, and prognosis of the cancer that affects the cells that protect neurons.

Symptoms and Causes

Glioblastoma, previously known as glioblastoma multiforme, is a type of cancer that develops in the brain or spinal cord. These tumors originate in glial cells, which are responsible for protecting, nourishing, and supporting neurons.

Although they are sometimes confused, glioma and glioblastoma are not the same. While a glioma refers to any tumor that forms in glial cells, glioblastoma is a type of glioma characterized by rapid growth and a high degree of malignancy. In short, glioblastoma is a grade IV glioma.

Glioblastomas can be classified into two types according to their characteristics:

  • Low-grade glioblastomas (grades I and II): the cellular appearance is almost normal. They grow slowly and are less aggressive.
  • High-grade glioblastomas (grades III and IV): tumors grow very rapidly and are highly aggressive. Their cellular composition differs significantly from that of healthy cells.

There are two types of glioblastomas depending on their evolution:

  • Primary glioblastoma: the most common form (approximately 90%). It develops rapidly and arises de novo, meaning without a prior smaller and less malignant glioma.
  • Secondary glioblastoma: develops from a slow-growing tumor. These are less aggressive than primary glioblastomas.

The prognosis of glioblastoma is generally unfavorable, although it varies widely depending on patient characteristics and tumor malignancy grade. The five-year survival rate typically ranges between 20% and 24%, as this cancer is highly resistant to therapy. Current treatments can slow tumor growth and reduce symptoms, but the average life expectancy is between 12 and 15 months from diagnosis. At present, multiple scientific studies are underway to identify more effective therapies for glioblastoma.

Symptoms

Common symptoms of glioblastoma include:

  • Headache (more intense in the morning).
  • Drowsiness.
  • Nausea and vomiting.
  • Seizures.
  • Cognitive impairment.
  • Memory loss.
  • Balance or coordination problems.
  • Irritability, personality changes.
  • Hemorrhage.
  • Reduced tactile sensitivity.
  • Depending on tumor location, specific symptoms such as:
    • Speech difficulties.
    • Unilateral loss of strength.
    • Visual field impairment.

Causes

The exact causes of glioblastoma formation are unknown.

Cancer, in general, develops when cellular DNA undergoes changes, causing cancer cells to grow faster than normal and survive longer than healthy cells. As a result, they accumulate and form tissue masses known as tumors.

Risk factors

Although the exact causes of glioblastoma are not known, studies have identified several factors commonly present in patients and therefore considered to increase risk:

  • Age: more common between 55 and 75 years; however, secondary glioblastomas often occur in younger patients.
  • Degenerative brain diseases.
  • Exposure to radiation, typically radiotherapy to the head for other conditions.
  • Weakened immune system.
  • Family history of:
  • Glioblastoma.
  • Neurofibromatosis type 1 or type 2.
  • Tuberous sclerosis.
  • Von Hippel–Lindau syndrome.
  • Li-Fraumeni syndrome.
  • Turcot syndrome.

Complications

Complications associated with glioblastoma are often severe. The most significant include:

  • Cognitive damage: confusion, memory impairment, difficulty concentrating, language disturbances, or impaired reasoning.
  • Psychological damage: personality changes, anxiety, or depression.
  • Edema: inflammation and fluid accumulation in brain tissue.
  • Hydrocephalus: accumulation of cerebrospinal fluid in the brain ventricles.
  • Seizures, loss of consciousness, or sensory disturbances.
  • Death.

Prevention

Glioblastoma cannot be prevented. Nevertheless, adopting a healthy lifestyle and avoiding exposure to ionizing radiation are recommended to reduce risk.

Which specialist treats glioblastoma?

Treatment of glioblastoma requires collaboration among specialists in neurology, neurosurgery, medical oncology, and radiation oncology.

Diagnosis

After anamnesis, which includes evaluation of the patient’s medical and family history along with presenting symptoms, several tests are performed to diagnose glioblastoma multiforme. The most common are:

  • Neurological examination: assessment of:
    • Motor function: strength, reflexes, and limb sensitivity.
    • Coordination.
    • Balance.
    • Cranial nerves: vision, hearing, facial movement.
    • Cognitive status: orientation, memory, language.
  • Contrast-enhanced magnetic resonance imaging (MRI): the most commonly used test, as it provides highly detailed images of brain structures. It allows tumor localization, size assessment, and evaluation of affected tissues. Gadolinium contrast is typically used to better visualize tumor vascularization and assess blood–brain barrier permeability.
  • Computed tomography (CT) scan: less commonly used but indicated in patients who cannot undergo MRI. Although images are less precise, tumors can still be detected.
  • Positron emission tomography (PET): used to determine the true tumor margins, which are often not clearly defined on MRI. It is helpful for treatment planning and monitoring treatment effectiveness.
  • Biopsy: a tissue sample is obtained using a needle and analyzed in the laboratory to determine the presence of malignant cells.
  • Blood tests: scientific advances now allow blood analysis to detect tumor markers and identify genetic mutations in DNA, making it possible to confirm diagnosis without the need for biopsy.

Treatment

Glioblastoma treatment is individualized for each patient and typically involves a combination of different therapies aimed at eliminating all cancer cells. The most common approaches include:

  • Surgical intervention: highly effective for grade I and II glioblastomas that do not involve deep brain regions, as complete resection is often possible. In most grade III and IV cases, additional procedures are required, as complete removal is usually not feasible.
    The most commonly used minimally invasive procedure follows these steps:
    • Oral administration of 5-aminolevulinic acid (5-ALA) several hours before surgery, causing cancer cells to fluoresce.
    • Through a small incision, a surgical microscope with a blue filter is introduced to detect cancer cells, which appear bright pink.
    • Surgical instruments are inserted through two or three additional incisions to resect the tumor and remove as many malignant cells as possible.
  • Chemotherapy: chemical agents are administered to eliminate residual tumor cells after surgery. Approximately six cycles are usually required, often followed by radiotherapy sessions.
  • Radiotherapy: ionizing radiation is delivered directly to the tumor site to minimize damage to healthy tissue. When combined with surgery and chemotherapy, it provides favorable outcomes in patients with high-grade gliomas.
  • Currently, new strategies and clinical trials are underway with experimental drugs (molecules capable of crossing the blood–brain barrier; PARP inhibitors such as niraparib, which block DNA repair in cancer cells, enhancing radiotherapy effectiveness and prolonging survival).
Would you like an appointment with a specialist?